Quantitative assessment of WT1 expression by real time quantitative PCR in acute lymphoblastic leukemia (ALL) as a prognostic marker and monitor of minimal residual disease (MRD)
Azza sobieh Mohamed;
Abstract
Abstract
Wilms (WT1) is overexpressed in the majority (70-90%) of acute leukemias and has been identified as an independent adverse prognostic factor, a convenient minimal residual disease (MRD) marker and potential therapeutic target in acute leukemia.
Wilms (WT1) is overexpressed in the majority (70-90%) of acute leukemias and has been identified as an independent adverse prognostic factor, a convenient minimal residual disease (MRD) marker and potential therapeutic target in acute leukemia.
Other data
| Title | Quantitative assessment of WT1 expression by real time quantitative PCR in acute lymphoblastic leukemia (ALL) as a prognostic marker and monitor of minimal residual disease (MRD) | Other Titles | استخدام تقنية تفاعل انزيم البلمرة المتسلسل فاعلية الوقت للقياس الكمي لجين الويلميز في حالات لوكيميا الدم الليمفاوية الحاد واستخدامه كدلالة متابعة ولقياس أقل اثار مرضية | Authors | Azza sobieh Mohamed | Keywords | Quantitative assessment of WT1 expression by real time quantitative PCR in acute lymphoblastic leukemia (ALL) as a prognostic marker and monitor of minimal residual disease (MRD) | Issue Date | 2010 | Description | Abstract Wilms (WT1) is overexpressed in the majority (70-90%) of acute leukemias and has been identified as an independent adverse prognostic factor, a convenient minimal residual disease (MRD) marker and potential therapeutic target in acute leukemia. |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.